SHINE Medical Technologies moved one step closer Tuesday to building its $100 million radioisotope production facility in Janesville, Wis., that is expected to satisfy more than half the U.S. demand for the medical isotope molybdenum-99.
Nuclear Regulatory Commission…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.
